/
Stock
/
/

BIOHAVEN

BHVN Insider Trades:
Created with Highcharts 10.1.0PriceVolumeJan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '24Jan '25Jul '25030609012015018008k16k24k32k40k48k






Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-05
2025-05-07
BAILEY GREGORY
A - Grant
Stock Options (Right to buy)
31,716
$0.00
1
$1.61B
2025-05-05
2025-05-07
CHILDS JOHN
A - Grant
Stock Options (Right to buy)
31,716
$0.00
1
$1.61B
2025-05-05
2025-05-07
GREGORY JULIA
A - Grant
Stock Options (Right to buy)
31,716
$0.00
1
$1.61B
2025-05-05
2025-05-07
ANTONIJEVIC IRINA
A - Grant
Stock Options (Right to buy)
31,716
$0.00
1
$1.61B
2025-05-05
2025-05-07
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Options (Right to buy)
31,716
$0.00
1
$1.61B
2025-05-05
2025-05-07
HUGIN ROBERT
A - Grant
Stock Options (Right to buy)
31,716
$0.00
1
$1.61B
2025-05-05
2025-05-07
MEHTA KISHAN
A - Grant
Stock Options (Right to buy)
31,716
$0.00
1
$1.61B
2025-03-04
2025-03-05
CHILDS JOHN
P - Purchase
Common Shares
32,700
$30.00
981K
4
$1.61B
2024-04-22
2025-03-05
CHILDS JOHN
P - Purchase
Common Shares
73,170
$41.00
3.00M
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
112K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
10,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
57,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
343K
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
91,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-2,561
$39.00
-99,879
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
F - Tax
Common Shares
-2,331
$39.00
-90,909
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-1,117
$39.00
-43,563
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-6,805
$39.00
-265K
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,956
$39.00
-76,284
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Common Shares
4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
104K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
19,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
112K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
10,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
57,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
343K
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
91,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-2,561
$39.00
-99,879
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
F - Tax
Common Shares
-2,331
$39.00
-90,909
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-1,117
$39.00
-43,563
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-6,805
$39.00
-265K
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,956
$39.00
-76,284
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Common Shares
4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
104K
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
104K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
19,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
112K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
10,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
57,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
343K
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
10,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
30,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
57,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
343K
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
91,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
91,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-2,561
$39.00
-99,879
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
F - Tax
Common Shares
-2,331
$39.00
-90,909
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-1,117
$39.00
-43,563
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-2,561
$39.00
-99,879
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
F - Tax
Common Shares
-2,331
$39.00
-90,909
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-1,117
$39.00
-43,563
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-6,805
$39.00
-265K
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,956
$39.00
-76,284
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,956
$39.00
-76,284
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Common Shares
4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
104K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
19,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
19,000
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
112K
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-6,805
$39.00
-265K
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
4,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CAR BRUCE
Chief Scientific Officer
M - Exercise
Common Shares
4,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,500
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
14,250
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2025-01-05
2025-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2024-12-30
2024-12-31
CHILDS JOHN
P - Purchase
Common Shares
29,000
$36.00
1.04M
1
$1.61B
2024-10-02
2024-10-03
CHILDS JOHN
P - Purchase
Common Shares
21,052
$48.00
1.01M
1
$1.61B
2024-10-02
2024-10-03
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
21,052
$48.00
1.01M
1
$1.61B
2024-09-24
2024-09-25
BAILEY GREGORY
P - Purchase
Common Shares
5,000
$44.00
220K
1
$1.61B
2024-07-18
2024-07-19
CHILDS JOHN
P - Purchase
Common Shares
28,400
$36.00
1.02M
1
$1.61B
2024-06-17
2024-06-20
CAR BRUCE
Chief Scientific Officer
P - Purchase
Common Shares
30,000
$34.00
1.02M
1
$1.61B
2024-05-30
2024-05-31
CHILDS JOHN
P - Purchase
Common Shares
28,000
$36.00
1.01M
1
$1.61B
2024-05-13
2024-05-15
BAILEY GREGORY
P - Purchase
Common Shares
15,000
$34.00
510K
1
$1.61B
2024-05-13
2024-05-14
CHILDS JOHN
P - Purchase
Common Shares
28,500
$35.00
998K
1
$1.61B
2024-04-30
2024-05-02
ANTONIJEVIC IRINA
A - Grant
Stock Option (Right to Buy)
16,592
$0.00
1
$1.61B
2024-04-30
2024-05-02
BAILEY GREGORY
A - Grant
Stock Option (Right to Buy)
16,592
$0.00
1
$1.61B
2024-04-30
2024-05-02
CHILDS JOHN
A - Grant
Stock Option (Right to Buy)
16,592
$0.00
1
$1.61B
2024-04-30
2024-05-02
GREGORY JULIA
A - Grant
Stock Option (Right to Buy)
16,592
$0.00
1
$1.61B
2024-04-30
2024-05-02
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to Buy)
16,592
$0.00
1
$1.61B
2024-04-30
2024-05-02
HUGIN ROBERT
A - Grant
Stock Option (Right to Buy)
16,592
$0.00
1
$1.61B
2024-04-30
2024-05-02
MEHTA KISHAN
A - Grant
Stock Option (Right to Buy)
16,592
$0.00
1
$1.61B
2024-04-24
2024-04-25
BAILEY GREGORY
P - Purchase
Common Shares
25,503
$39.00
995K
1
$1.61B
2024-04-22
2024-04-23
BAILEY GREGORY
P - Purchase
Common Shares
48,780
$41.00
2.00M
1
$1.61B
2024-04-22
2024-04-23
CHILDS JOHN
P - Purchase
Common Shares
195K
$41.00
8.00M
3
$1.61B
2024-04-22
2024-04-23
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
122K
$41.00
5.00M
1
$1.61B
2024-04-05
2024-04-05
CHILDS JOHN
A - Grant
Common Shares
2,091
1
$1.61B
2024-04-05
2024-04-05
CORIC VLAD
Chief Executive Officer
A - Grant
Common Shares
694
3
$1.61B
2024-03-08
2024-03-08
CHILDS JOHN
A - Grant
Common Shares
19,412
1
$1.61B
2024-03-08
2024-03-08
CORIC VLAD
Chief Executive Officer
A - Grant
Common Shares
6,472
3
$1.61B
2024-01-08
2024-01-10
CORIC VLAD
Chief Executive Officer
A - Grant
Common Shares
16,168
3
$1.61B
2024-01-08
2024-01-10
CHILDS JOHN
J - Other
Common Shares
48,505
1
$1.61B
2024-01-02
2024-01-04
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
96,250
$0.00
1
$1.61B
2024-01-02
2024-01-04
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
96,250
$0.00
1
$1.61B
2024-01-02
2024-01-04
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
27,500
$0.00
1
$1.61B
2024-01-02
2024-01-04
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
275K
$0.00
1
$1.61B
2024-01-02
2024-01-04
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
96,250
$0.00
1
$1.61B
2023-12-29
2023-12-29
ANTONIJEVIC IRINA
M - Exercise
Stock Options (Right to Buy)
-11,000
$0.00
1
$1.61B
2023-12-29
2023-12-29
ANTONIJEVIC IRINA
M - Exercise
Common Shares
11,000
$0.00
1
$1.61B
2023-12-29
2023-12-29
ANTONIJEVIC IRINA
S - Sale
Common Shares
-11,000
$42.00
-462K
1
$1.61B
2023-11-02
2023-11-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-07
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
22,500
$0.00
1
$1.61B
2023-11-02
2023-11-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
225K
$0.00
1
$1.61B
2023-11-02
2023-11-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-06
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Options (Right to buy)
225K
$0.00
1
$1.61B
2023-11-02
2023-11-06
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-06
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-11-02
2023-11-06
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Stock Options (Right to buy)
22,500
$0.00
1
$1.61B
2023-11-02
2023-11-06
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
78,750
$0.00
1
$1.61B
2023-10-05
2023-10-10
CHILDS JOHN
P - Purchase
Common Shares
455K
$22.00
10.00M
2
$1.61B
2023-10-05
2023-10-10
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
114K
$22.00
2.50M
1
$1.61B
2023-10-05
2023-10-10
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Share
341K
$22.00
7.50M
1
$1.61B
2023-10-05
2023-10-06
BUTEN MATTHEW
Chief Financial Officer
P - Purchase
Common Shares
22,727
$22.00
500K
1
$1.61B
2023-10-04
2023-10-06
BAILEY GREGORY
P - Purchase
Common Shares
17,817
$23.00
410K
1
$1.61B
2023-08-30
2023-08-31
CHILDS JOHN
P - Purchase
Common Shares
50,000
$18.00
900K
1
$1.61B
2023-08-04
2023-08-07
CHILDS JOHN
P - Purchase
Common Shares
100K
$20.00
2.00M
1
$1.61B
2023-05-02
2023-05-04
HUGIN ROBERT
A - Grant
Stock Option (Right to Buy)
52,906
$0.00
1
$1.61B
2023-05-02
2023-05-04
ANTONIJEVIC IRINA
A - Grant
Stock Option (Right to Buy)
52,906
$0.00
1
$1.61B
2023-05-02
2023-05-04
BAILEY GREGORY
A - Grant
Stock Option (Right to Buy)
52,906
$0.00
1
$1.61B
2023-05-02
2023-05-04
CHILDS JOHN
A - Grant
Stock Option (Right to Buy)
52,906
$0.00
1
$1.61B
2023-05-02
2023-05-04
GREGORY JULIA
A - Grant
Stock Option (Right to Buy)
52,906
$0.00
1
$1.61B
2023-05-02
2023-05-04
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to Buy)
52,906
$0.00
1
$1.61B
2023-05-02
2023-05-04
MEHTA KISHAN
A - Grant
Stock Option (Right to Buy)
52,906
$0.00
1
$1.61B
2022-10-25
2023-03-22
CHILDS JOHN
P - Purchase
Common Shares
3.71M
$11.00
41M
2
$1.61B
2022-10-31
2022-11-01
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Stock
25,800
$16.00
413K
1
$1.61B
2022-10-28
2022-10-31
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
142K
$15.00
2.13M
2
$1.61B
2022-10-25
2022-10-26
CHILDS JOHN
P - Purchase
Common Shares
3.90M
$11.00
43M
1
$1.61B
2022-10-25
2022-10-26
BAILEY GREGORY
P - Purchase
Common Shares
200K
$11.00
2.20M
1
$1.61B
2022-10-25
2022-10-26
GREGORY JULIA
P - Purchase
Common Shares
9,523
$11.00
105K
1
$1.61B
2022-10-25
2022-10-26
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
853K
$11.00
9.39M
1
$1.61B
2022-10-25
2022-10-26
BUTEN MATTHEW
Chief Financial Officer
P - Purchase
Common Shares
143K
$11.00
1.57M
1
$1.61B
2022-10-03
2022-10-12
HUGIN ROBERT
F - Tax
Common Shares
-12,959
$8.00
-104K
1
$1.61B
2022-10-03
2022-10-12
HEFFERNAN MICHAEL THOMAS
F - Tax
Common Shares
-9,699
$8.00
-77,592
1
$1.61B
2022-10-05
2022-10-06
CORIC VLAD
Chief Executive Officer
P - Purchase
Common Shares
486K
$10.00
4.86M
9
$1.61B
2022-10-05
2022-10-05
CHILDS JOHN
P - Purchase
Common Shares
274K
$9.00
2.47M
2
$1.61B
2022-10-03
2022-10-05
BAILEY GREGORY
J - Other
Common Shares
1.29M
$0.00
1
$1.61B
2022-10-03
2022-10-05
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.
J - Other
Common Shares
36M
$0.00
1
$1.61B
2022-10-03
2022-10-05
BIOHAVEN PHARMACEUTICAL HOLDING CO LTD.
J - Other
Common Shares
-36M
$0.00
1
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
J - Other
Stock Options (Right to Buy)
13,000
2
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
J - Other
Common Shares
21,838
$0.00
2
$1.61B
2022-10-03
2022-10-05
CHILDS JOHN
J - Other
Stock Options (Right to Buy)
10,117
2
$1.61B
2022-10-03
2022-10-05
CHILDS JOHN
J - Other
Common Shares
1.52M
$0.00
2
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
J - Other
Stock Options (Right to Buy)
586K
14
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
J - Other
Common Shares
567K
$0.00
10
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
J - Other
Common Shares
461K
$0.00
4
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
J - Other
Stock Options (Right to Buy)
116K
12
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
J - Other
Common Shares
17,951
$0.00
4
$1.61B
2022-10-03
2022-10-05
GREGORY JULIA
J - Other
Stock Options (Right to Buy)
28,117
4
$1.61B
2022-10-03
2022-10-05
HEFFERNAN MICHAEL THOMAS
J - Other
Stock Options (Right to Buy)
23,217
3
$1.61B
2022-10-03
2022-10-05
HEFFERNAN MICHAEL THOMAS
J - Other
Common Shares
1,660
$0.00
1
$1.61B
2022-10-03
2022-10-05
HUGIN ROBERT
J - Other
Stock Options (Right to Buy)
19,591
3
$1.61B
2022-10-03
2022-10-05
HUGIN ROBERT
J - Other
Common Shares
3,158
$0.00
2
$1.61B
2022-10-03
2022-10-05
MEHTA KISHAN
J - Other
Stock Options (Right to Buy)
28,121
4
$1.61B
2022-10-03
2022-10-05
MEHTA KISHAN
J - Other
Common Shares
6,257
$0.00
2
$1.61B
2022-10-03
2022-10-05
BAILEY GREGORY
M - Exercise
Stock Options (Right to Buy)
-18,000
$0.00
2
$1.61B
2022-10-03
2022-10-05
BAILEY GREGORY
M - Exercise
Stock Options (Right to buy)
-10,117
$0.00
2
$1.61B
2022-10-03
2022-10-05
BAILEY GREGORY
M - Exercise
Common Shares
28,117
$3.00
84,351
4
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Stock Options (Right to Buy)
-13,000
$0.00
2
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
13,000
$6.00
78,000
2
$1.61B
2022-10-03
2022-10-05
CHILDS JOHN
M - Exercise
Stock Options (Right to Buy)
-10,117
$0.00
2
$1.61B
2022-10-03
2022-10-05
CHILDS JOHN
M - Exercise
Common Shares
10,117
$4.00
40,468
2
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
M - Exercise
Stock Option (Right to Buy)
-258K
$0.00
5
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
586K
$1.00
586K
14
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Stock Options (Right to Buy)
-98,510
$0.00
10
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
116K
$2.00
231K
12
$1.61B
2022-10-03
2022-10-05
GREGORY JULIA
M - Exercise
Stock Options (Right to Buy)
-28,117
$0.00
4
$1.61B
2022-10-03
2022-10-05
GREGORY JULIA
M - Exercise
Common Shares
28,117
$3.00
84,351
4
$1.61B
2022-10-03
2022-10-05
HEFFERNAN MICHAEL THOMAS
M - Exercise
Stock Options (Right to Buy)
-23,217
$0.00
3
$1.61B
2022-10-03
2022-10-05
HEFFERNAN MICHAEL THOMAS
M - Exercise
Common Shares
23,217
$3.00
69,651
3
$1.61B
2022-10-03
2022-10-05
HUGIN ROBERT
M - Exercise
Stock Options (Right to Buy)
-19,591
$0.00
3
$1.61B
2022-10-03
2022-10-05
HUGIN ROBERT
M - Exercise
Common Shares
19,591
$4.00
78,364
3
$1.61B
2022-10-03
2022-10-05
MEHTA KISHAN
M - Exercise
Stock Options (Right to Buy)
-28,121
$0.00
4
$1.61B
2022-10-03
2022-10-05
MEHTA KISHAN
M - Exercise
Common Shares
28,121
$3.00
84,363
4
$1.61B
2022-10-03
2022-10-05
CHILDS JOHN
J - Other
Common Shares
1.52M
$0.00
1
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
M - Exercise
Stock Options (Right to Buy)
-329K
$0.00
9
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Stock Option (Right to Buy)
-12,500
$0.00
1
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Stock Options (Right to buy)
-4,500
$0.00
1
$1.61B
2022-10-03
2022-10-05
ANTONIJEVIC IRINA
A - Grant
Stock Options (Right to Buy)
125K
$0.00
1
$1.61B
2022-10-03
2022-10-05
BAILEY GREGORY
A - Grant
Stock Options (Right to Buy)
125K
$0.00
1
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Stock Options (Right to Buy)
300K
$0.00
1
$1.61B
2022-10-03
2022-10-05
CAR BRUCE
Chief Scientific Officer
A - Grant
Stock Options (Right to Buy)
300K
$0.00
1
$1.61B
2022-10-03
2022-10-05
CHILDS JOHN
A - Grant
Stock Options (Right to Buy)
125K
$0.00
1
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
950K
$0.00
1
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Stock Options (Right to buy)
300K
$0.00
1
$1.61B
2022-10-03
2022-10-05
GREGORY JULIA
A - Grant
Stock Options (Right to buy)
125K
$0.00
1
$1.61B
2022-10-03
2022-10-05
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Options (Right to Buy)
125K
$0.00
1
$1.61B
2022-10-03
2022-10-05
HUGIN ROBERT
A - Grant
Stock Options (Right to Buy)
125K
$0.00
1
$1.61B
2022-10-03
2022-10-05
MEHTA KISHAN
A - Grant
Stock Options (Right to buy)
125K
$0.00
1
$1.61B
2022-10-03
2022-10-05
BAILEY GREGORY
F - Tax
Common Shares
-11,975
$8.00
-95,800
1
$1.61B
2022-10-03
2022-10-05
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-11,042
$8.00
-88,336
1
$1.61B
2022-10-03
2022-10-05
CHILDS JOHN
F - Tax
Common Shares
-5,507
$8.00
-44,056
1
$1.61B
2022-10-03
2022-10-05
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-116K
$8.00
-928K
1
$1.61B
2022-10-03
2022-10-05
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-37,492
$7.00
-262K
1
$1.61B
2022-10-03
2022-10-05
GREGORY JULIA
F - Tax
Common Shares
-11,975
$8.00
-95,800
1
$1.61B
2022-10-03
2022-10-05
HEFFERNAN MICHAEL THOMAS
F - Tax
Common Shares
-5,507
$8.00
-44,056
1
$1.61B
2022-10-03
2022-10-05
HUGIN ROBERT
F - Tax
Common Shares
-3,263
$8.00
-26,104
1
$1.61B
2022-10-03
2022-10-05
MEHTA KISHAN
F - Tax
Common Shares
-11,716
$7.00
-82,012
1
$1.61B
2022-10-03
2022-10-05
ANTONIJEVIC IRINA
J - Other
Common Shares
2,535
$0.00
1
$1.61B
2022-10-03
2022-10-05
BAILEY GREGORY
J - Other
Stock Options (Right to Buy)
28,117
4
$1.61B
2022-10-03
2022-10-03
CORIC VLAD
Chief Executive Officer
D - Sale to Issuer
Restricted Share Unit Award
-106K
8
$1.61B
2022-10-03
2022-10-03
BAILEY GREGORY
D - Sale to Issuer
Stock Options (Right to Buy)
-56,235
4
$1.61B
2022-10-03
2022-10-03
BAILEY GREGORY
D - Sale to Issuer
Common Shares
-2.58M
$149.00
-385M
1
$1.61B
2022-10-03
2022-10-03
BUTEN MATTHEW
Chief Financial Officer
D - Sale to Issuer
Restricted Share Unit Award
-37,500
1
$1.61B
2022-10-03
2022-10-03
BUTEN MATTHEW
Chief Financial Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-26,000
2
$1.61B
2022-10-03
2022-10-03
BUTEN MATTHEW
Chief Financial Officer
D - Sale to Issuer
Common Shares
-6,177
$149.00
-920K
1
$1.61B
2022-10-03
2022-10-03
CHILDS JOHN
D - Sale to Issuer
Stock Options (Right to Buy)
-20,235
2
$1.61B
2022-10-03
2022-10-03
CHILDS JOHN
D - Sale to Issuer
Common Shares
-3.04M
$149.00
-452M
2
$1.61B
2022-10-03
2022-10-03
CLARK GEORGE
VP, Chief Accounting Officer
D - Sale to Issuer
Restricted Share Unit Award
-21,750
5
$1.61B
2022-10-03
2022-10-03
CLARK GEORGE
VP, Chief Accounting Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-33,375
9
$1.61B
2022-10-03
2022-10-03
CLARK GEORGE
VP, Chief Accounting Officer
D - Sale to Issuer
Common Shares
-4,292
$149.00
-640K
1
$1.61B
2022-10-03
2022-10-03
CONWAY CHARLES
Chief Scientific Officer
D - Sale to Issuer
Restricted Share Unit Award
-22,000
3
$1.61B
2022-10-03
2022-10-03
CONWAY CHARLES
Chief Scientific Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-253K
12
$1.61B
2022-10-03
2022-10-03
CONWAY CHARLES
Chief Scientific Officer
D - Sale to Issuer
Common Shares
-22,362
$149.00
-3.33M
1
$1.61B
2022-10-03
2022-10-03
ANTONIJEVIC IRINA
D - Sale to Issuer
Restricted Share Unit Award
-5,070
1
$1.61B
2022-10-03
2022-10-03
CORIC VLAD
Chief Executive Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-1.17M
14
$1.61B
2022-10-03
2022-10-03
CORIC VLAD
Chief Executive Officer
D - Sale to Issuer
Common Shares
-923K
$149.00
-138M
4
$1.61B
2022-10-03
2022-10-03
ENGELHART JAMES
Strategic Advisor
D - Sale to Issuer
Restricted Share Unit Award
-20,950
3
$1.61B
2022-10-03
2022-10-03
ENGELHART JAMES
Strategic Advisor
D - Sale to Issuer
Stock Options (Right to Buy)
-279K
10
$1.61B
2022-10-03
2022-10-03
ENGELHART JAMES
Strategic Advisor
D - Sale to Issuer
Stock Options (Right to buy)
-83,792
1
$1.61B
2022-10-03
2022-10-03
ENGELHART JAMES
Strategic Advisor
D - Sale to Issuer
Common Shares
-15,900
$149.00
-2.37M
1
$1.61B
2022-10-03
2022-10-03
GENTILE KIMBERLY
SVP, Clinical Operations
D - Sale to Issuer
Restricted Share Unit Award
-24,250
3
$1.61B
2022-10-03
2022-10-03
GENTILE KIMBERLY
SVP, Clinical Operations
D - Sale to Issuer
Stock Options (Right to Buy)
-231K
12
$1.61B
2022-10-03
2022-10-03
GENTILE KIMBERLY
SVP, Clinical Operations
D - Sale to Issuer
Common Shares
-11,653
$149.00
-1.74M
1
$1.61B
2022-10-03
2022-10-03
GREGORY JULIA
D - Sale to Issuer
Stock Options (Right to Buy)
-56,235
4
$1.61B
2022-10-03
2022-10-03
HEFFERNAN MICHAEL THOMAS
D - Sale to Issuer
Restricted Share Unit Award
-3,320
1
$1.61B
2022-10-03
2022-10-03
HEFFERNAN MICHAEL THOMAS
D - Sale to Issuer
Stock Options (Right to Buy)
-46,435
3
$1.61B
2022-10-03
2022-10-03
HUGIN ROBERT
D - Sale to Issuer
Restricted Share Unit Award
-3,417
1
$1.61B
2022-10-03
2022-10-03
HUGIN ROBERT
D - Sale to Issuer
Stock Options (Right to Buy)
-39,183
3
$1.61B
2022-10-03
2022-10-03
HUGIN ROBERT
D - Sale to Issuer
Common Shares
-2,900
$149.00
-432K
1
$1.61B
2022-10-03
2022-10-03
JONES WILLIAM JR
CCO-Migraine & Common Disease
D - Sale to Issuer
Restricted Share Unit Award
-24,250
3
$1.61B
2022-10-03
2022-10-03
JONES WILLIAM JR
CCO-Migraine & Common Disease
D - Sale to Issuer
Stock Options (Right to Buy)
-150K
8
$1.61B
2022-10-03
2022-10-03
JONES WILLIAM JR
CCO-Migraine & Common Disease
D - Sale to Issuer
Common Shares
-14,226
$149.00
-2.12M
1
$1.61B
2022-10-03
2022-10-03
MEHTA KISHAN
D - Sale to Issuer
Restricted Share Unit Award
-1,875
1
$1.61B
2022-10-03
2022-10-03
MEHTA KISHAN
D - Sale to Issuer
Stock Options (Right to Buy)
-56,243
4
$1.61B
2022-10-03
2022-10-03
MEHTA KISHAN
D - Sale to Issuer
Common Shares
-10,640
$149.00
-1.59M
1
$1.61B
2022-10-03
2022-10-03
STOCK ELYSE
Chief Medical Officer
D - Sale to Issuer
Restricted Share Unit Award
-27,063
6
$1.61B
2022-10-03
2022-10-03
STOCK ELYSE
Chief Medical Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-176K
14
$1.61B
2022-10-03
2022-10-03
STOCK ELYSE
Chief Medical Officer
D - Sale to Issuer
Common Shares
-16,464
$149.00
-2.45M
2
$1.61B
2022-10-03
2022-10-03
TILTON JOHN
Chief Commercial Officer
D - Sale to Issuer
Restricted Share Unit Award
-6,375
3
$1.61B
2022-10-03
2022-10-03
TILTON JOHN
Chief Commercial Officer
D - Sale to Issuer
Stock Options (Right to Buy)
-120K
11
$1.61B
2022-10-03
2022-10-03
TILTON JOHN
Chief Commercial Officer
D - Sale to Issuer
Common Shares
-6,682
$149.00
-996K
2
$1.61B
2022-08-19
2022-08-22
BAILEY GREGORY
P - Purchase
Common Stock
38,000
$148.00
5.62M
1
$1.61B
2022-05-11
2022-05-12
ANTONIJEVIC IRINA
A - Grant
Restricted Share Unit Award
5,070
$0.00
1
$1.61B
2022-05-10
2022-05-12
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Employee Stock Option (right to buy)
-2,250
$0.00
1
$1.61B
2022-05-10
2022-05-12
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
2,250
$54.00
122K
1
$1.61B
2022-05-10
2022-05-12
CLARK GEORGE
VP, Chief Accounting Officer
S - Sale
Common Shares
-4,200
$142.00
-596K
1
$1.61B
2022-04-28
2022-04-29
MEHTA KISHAN
A - Grant
Stock Option (Right to Buy)
8,239
$0.00
1
$1.61B
2022-04-28
2022-04-29
HUGIN ROBERT
A - Grant
Stock Option (Right to Buy)
8,239
$0.00
1
$1.61B
2022-04-28
2022-04-29
BAILEY GREGORY
A - Grant
Stock Option (Right to Buy)
8,239
$0.00
1
$1.61B
2022-04-28
2022-04-29
CHILDS JOHN
A - Grant
Stock Option (Right to Buy)
8,239
$0.00
1
$1.61B
2022-04-28
2022-04-29
GREGORY JULIA
A - Grant
Stock Option (Right to Buy)
8,239
$0.00
1
$1.61B
2022-04-28
2022-04-29
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to Buy)
8,239
$0.00
1
$1.61B
2021-11-30
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-5,475
$0.00
1
$1.61B
2021-11-30
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
5,475
$0.00
1
$1.61B
2021-11-26
2022-02-11
CORIC VLAD
Chief Executive Officer
G - Gift
Common Shares
-35,000
$0.00
2
$1.61B
2021-11-22
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
491K
$0.00
1
$1.61B
2021-11-22
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-491K
$0.00
1
$1.61B
2021-10-14
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-14,357
$0.00
2
$1.61B
2021-10-14
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
14,357
$0.00
2
$1.61B
2021-06-21
2022-02-11
CORIC VLAD
Chief Executive Officer
G - Gift
Common Shares
29,783
$0.00
1
$1.61B
2021-06-21
2022-02-11
CORIC VLAD
Chief Executive Officer
G - Gift
Common Shares
-29,783
$0.00
1
$1.61B
2021-05-21
2022-02-11
DOOGAN DECLAN
I - Discretionary Transaction
Common Shares
-170K
$0.00
1
$1.61B
2021-05-21
2022-02-11
DOOGAN DECLAN
I - Discretionary Transaction
Common Shares
170K
$0.00
1
$1.61B
2021-05-21
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-20,800
$0.00
1
$1.61B
2021-05-21
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
20,800
$0.00
1
$1.61B
2021-05-18
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
166K
$0.00
3
$1.61B
2021-05-18
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-166K
$0.00
3
$1.61B
2021-03-24
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
133K
$0.00
1
$1.61B
2021-03-24
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-133K
$0.00
1
$1.61B
2021-03-22
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
22,315
$0.00
1
$1.61B
2021-03-22
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-22,315
$0.00
1
$1.61B
2021-03-18
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-140K
$0.00
1
$1.61B
2021-03-18
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
140K
$0.00
1
$1.61B
2021-03-16
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
60,775
$0.00
1
$1.61B
2021-03-16
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-60,775
$0.00
1
$1.61B
2021-03-08
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
-210K
$0.00
1
$1.61B
2021-03-08
2022-02-11
DOOGAN DECLAN
G - Gift
Common Shares
210K
$0.00
2
$1.61B
2020-06-16
2022-02-11
DOOGAN DECLAN
S - Sale
Common Shares
-25,508
$69.00
-1.76M
2
$1.61B
2020-06-15
2022-02-11
DOOGAN DECLAN
S - Sale
Common Shares
-15,798
$68.00
-1.07M
2
$1.61B
2020-06-12
2022-02-11
DOOGAN DECLAN
S - Sale
Common Shares
-25,914
$66.00
-1.71M
2
$1.61B
2020-06-11
2022-02-11
DOOGAN DECLAN
S - Sale
Common Shares
-25,039
$65.00
-1.63M
2
$1.61B
2022-01-19
2022-01-24
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Employee Stock Option (right to buy)
-5,670
$0.00
2
$1.61B
2022-01-19
2022-01-24
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
5,670
$47.00
266K
2
$1.61B
2022-01-19
2022-01-24
CLARK GEORGE
VP, Chief Accounting Officer
S - Sale
Common Shares
-9,375
$117.00
-1.10M
4
$1.61B
2022-01-10
2022-01-12
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-464
$129.00
-59,856
1
$1.61B
2022-01-10
2022-01-12
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-1,000
$0.00
1
$1.61B
2022-01-10
2022-01-12
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
1,000
$0.00
1
$1.61B
2022-01-10
2022-01-12
MEHTA KISHAN
M - Exercise
Restricted Share Unit Award
-1,875
$0.00
1
$1.61B
2022-01-10
2022-01-12
MEHTA KISHAN
M - Exercise
Common Shares
1,875
$0.00
1
$1.61B
2022-01-10
2022-01-12
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
937
$0.00
1
$1.61B
2022-01-10
2022-01-12
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
937
$0.00
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
40,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
13,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
BUTEN MATTHEW
Chief Financial Officer
A - Grant
Employee Stock Option (Right to Buy)
26,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Employee Stock Option (right to buy)
10,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
A - Grant
Restricted Share Unit Award
5,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Employee Stock Option (right to buy)
23,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
11,500
$0.00
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
A - Grant
Stock Option (Right to Buy)
70,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
A - Grant
Employee Stock Option (Right to Buy)
26,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
A - Grant
Restricted Share Unit Award
13,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Employee Stock Option (Right to Buy)
26,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
A - Grant
Restricted Share Unit Award
17,000
$0.00
2
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
A - Grant
Employee Stock Option (right to buy)
7,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
A - Grant
Restricted Share Unit Award
3,500
$0.00
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-522
$129.00
-67,338
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-4,634
$129.00
-598K
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
F - Tax
Common Shares
-1,279
$129.00
-165K
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
F - Tax
Common Shares
-1,631
$129.00
-210K
1
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
F - Tax
Common Shares
-1,539
$129.00
-199K
1
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
F - Tax
Common Shares
-342
$129.00
-44,118
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-1,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
1,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-10,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
10,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
M - Exercise
Restricted Share Unit Award
-3,250
$0.00
1
$1.61B
2022-01-07
2022-01-07
ENGELHART JAMES
Strategic Advisor
M - Exercise
Common Shares
3,250
$0.00
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2022-01-07
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
M - Exercise
Employee Stock Option (right to buy)
26,000
$0.00
1
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
-4,250
$0.00
2
$1.61B
2022-01-07
2022-01-07
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
4,250
$0.00
2
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
M - Exercise
Restricted Share Unit Award
-875
$0.00
1
$1.61B
2022-01-07
2022-01-07
TILTON JOHN
Chief Commercial Officer
M - Exercise
Common Shares
875
$0.00
1
$1.61B
2022-01-06
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
TILTON JOHN
Chief Commercial Officer
M - Exercise
Restricted Share Unit Award
-1,250
$0.00
1
$1.61B
2022-01-06
2022-01-07
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-5,854
$124.00
-726K
1
$1.61B
2022-01-06
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
F - Tax
Common Shares
-1,800
$124.00
-223K
1
$1.61B
2022-01-06
2022-01-07
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
5,000
$0.00
2
$1.61B
2022-01-06
2022-01-07
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
2
$1.61B
2022-01-06
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Common Shares
5,000
$0.00
1
$1.61B
2022-01-06
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
1
$1.61B
2022-01-06
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-409
$124.00
-50,716
1
$1.61B
2022-01-06
2022-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
12,500
$0.00
1
$1.61B
2022-01-06
2022-01-07
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-12,500
$0.00
1
$1.61B
2022-01-06
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
875
$0.00
1
$1.61B
2022-01-06
2022-01-07
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-875
$0.00
1
$1.61B
2022-01-06
2022-01-07
TILTON JOHN
Chief Commercial Officer
F - Tax
Common Shares
-551
$124.00
-68,324
1
$1.61B
2022-01-06
2022-01-07
STOCK ELYSE
Chief Medical Officer
F - Tax
Common Shares
-1,838
$124.00
-228K
1
$1.61B
2022-01-06
2022-01-07
JONES WILLIAM JR
CCO-Migraine & Common Disease
F - Tax
Common Shares
-2,230
$124.00
-277K
1
$1.61B
2022-01-06
2022-01-07
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,800
$124.00
-223K
1
$1.61B
2022-01-06
2022-01-07
ENGELHART JAMES
Strategic Advisor
F - Tax
Common Shares
-1,532
$124.00
-190K
1
$1.61B
2022-01-06
2022-01-07
TILTON JOHN
Chief Commercial Officer
M - Exercise
Common Shares
1,250
$0.00
1
$1.61B
2022-01-06
2022-01-07
ENGELHART JAMES
Strategic Advisor
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2022-01-06
2022-01-07
ENGELHART JAMES
Strategic Advisor
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-12-31
2022-01-04
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-12,500
1
$1.61B
2021-12-31
2022-01-04
BUTEN MATTHEW
Chief Financial Officer
M - Exercise
Common Shares
12,500
$0.00
1
$1.61B
2021-12-31
2022-01-04
BUTEN MATTHEW
Chief Financial Officer
F - Tax
Common Shares
-6,323
$138.00
-873K
1
$1.61B
2021-12-20
2021-12-22
GREGORY JULIA
S - Sale
Common Shares
-12,000
$125.00
-1.50M
1
$1.61B
2021-12-20
2021-12-22
HEFFERNAN MICHAEL THOMAS
A - Grant
Restricted Share Unit Award
3,320
$0.00
1
$1.61B
2021-12-20
2021-12-22
HUGIN ROBERT
A - Grant
Restricted Share Unit Award
3,417
$0.00
1
$1.61B
2021-12-20
2021-12-22
GREGORY JULIA
M - Exercise
Employee Stock Option (Right to Buy)
-12,000
$0.00
1
$1.61B
2021-12-20
2021-12-22
GREGORY JULIA
M - Exercise
Common Shares
12,000
$24.00
288K
1
$1.61B
2021-12-20
2021-12-22
CLARK GEORGE
VP, Chief Accounting Officer
S - Sale
Common Shares
-1,915
$124.00
-237K
1
$1.61B
2021-12-15
2021-12-16
STOCK ELYSE
Chief Medical Officer
M - Exercise
Employee Stock Option (Right to Buy)
-21,919
$0.00
2
$1.61B
2021-12-15
2021-12-16
STOCK ELYSE
Chief Medical Officer
S - Sale
Common Shares
-21,919
$105.00
-2.30M
2
$1.61B
2021-12-15
2021-12-16
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
21,919
$14.00
307K
2
$1.61B
2021-12-14
2021-12-16
STOCK ELYSE
Chief Medical Officer
S - Sale
Common Shares
-6,939
$105.00
-729K
1
$1.61B
2021-12-14
2021-12-16
STOCK ELYSE
Chief Medical Officer
M - Exercise
Employee Stock Option (Right to Buy)
-6,939
$0.00
2
$1.61B
2021-12-14
2021-12-16
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
6,939
$16.00
111K
2
$1.61B
2021-12-08
2021-12-14
BUTEN MATTHEW
Officer
A - Grant
Restricted Share Unit Award
50,000
1
$1.61B
2021-12-10
2021-12-10
ENGELHART JAMES
Chief Financial Officer
S - Sale
Common Shares
-35,000
$103.00
-3.60M
3
$1.61B
2021-12-10
2021-12-10
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Employee Stock Option (Right to Buy)
-35,000
$0.00
1
$1.61B
2021-12-10
2021-12-10
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Common Shares
35,000
$0.00
1
$1.61B
2021-11-29
2021-12-01
DOOGAN DECLAN
S - Sale
Common Shares
-24,525
$113.00
-2.77M
2
$1.61B
2021-11-26
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
1
$1.61B
2021-11-26
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
F - Tax
Common Shares
-2,318
$116.00
-269K
1
$1.61B
2021-11-26
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
5,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
10,950
$0.00
1
$1.61B
2021-11-25
2021-11-26
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-5,075
$116.00
-589K
1
$1.61B
2021-11-25
2021-11-26
ENGELHART JAMES
Chief Financial Officer
F - Tax
Common Shares
-1,715
$116.00
-199K
1
$1.61B
2021-11-25
2021-11-26
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,738
$116.00
-202K
1
$1.61B
2021-11-25
2021-11-26
JONES WILLIAM JR
CCO-Migraine & Common Disease
F - Tax
Common Shares
-1,305
$116.00
-151K
1
$1.61B
2021-11-25
2021-11-26
STOCK ELYSE
Chief Medical Officer
F - Tax
Common Shares
-1,599
$116.00
-185K
1
$1.61B
2021-11-25
2021-11-26
TILTON JOHN
Chief Commercial Officer
F - Tax
Common Shares
-492
$116.00
-57,072
1
$1.61B
2021-11-25
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-3,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Common Shares
3,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-10,950
$0.00
1
$1.61B
2021-11-25
2021-11-26
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-3,700
$0.00
1
$1.61B
2021-11-25
2021-11-26
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Common Shares
3,700
$0.00
1
$1.61B
2021-11-25
2021-11-26
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-11-25
2021-11-26
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2021-11-25
2021-11-26
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Restricted Share Unit Award
-3,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Common Shares
3,000
$0.00
1
$1.61B
2021-11-25
2021-11-26
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
-3,375
$0.00
1
$1.61B
2021-11-25
2021-11-26
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
3,375
$0.00
1
$1.61B
2021-11-25
2021-11-26
TILTON JOHN
Chief Commercial Officer
M - Exercise
Restricted Share Unit Award
-1,250
$0.00
1
$1.61B
2021-11-25
2021-11-26
TILTON JOHN
Chief Commercial Officer
M - Exercise
Common Shares
1,250
$0.00
1
$1.61B
2021-11-23
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Common Shares
10,885
$36.00
392K
2
$1.61B
2021-11-23
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Common Shares
1,915
$32.00
61,280
1
$1.61B
2021-11-23
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Employee Stock Option (Right to Buy)
-10,885
$0.00
2
$1.61B
2021-11-23
2021-11-26
CLARK GEORGE
VP, Chief Accounting Officer
M - Exercise
Employee Stock Option (right to buy)
-1,915
$0.00
1
$1.61B
2017-12-07
2021-11-26
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Employee Stock Option (Right to Buy)
42,612
$0.00
1
$1.61B
2021-11-16
2021-11-17
DOOGAN DECLAN
S - Sale
Common Shares
-37,740
$117.00
-4.42M
3
$1.61B
2021-11-16
2021-11-17
DOOGAN DECLAN
M - Exercise
Stock Option (Right to buy)
-559K
$0.00
7
$1.61B
2021-11-16
2021-11-17
DOOGAN DECLAN
M - Exercise
Common Shares
559K
$8.00
4.47M
7
$1.61B
2021-11-15
2021-11-17
CHILDS JOHN
M - Exercise
Stock Option (Right to Buy)
-474K
$0.00
7
$1.61B
2021-11-15
2021-11-17
CHILDS JOHN
M - Exercise
Common Shares
474K
$8.00
3.79M
7
$1.61B
2021-11-10
2021-11-10
CHILDS JOHN
P - Purchase
Common Shares
5,000
$123.00
615K
2
$1.61B
2021-06-15
2021-06-17
MEHTA KISHAN
A - Grant
Stock Options (Right to buy)
13,004
$0.00
1
$1.61B
2021-05-05
2021-05-07
BAILEY GREGORY
A - Grant
Stock Option (Right to Buy)
11,996
$0.00
1
$1.61B
2021-05-05
2021-05-07
HUGIN ROBERT
A - Grant
Stock Option (Right to Buy)
11,996
$0.00
1
$1.61B
2021-05-05
2021-05-07
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (Right to Buy)
11,996
$0.00
1
$1.61B
2021-05-05
2021-05-07
GREGORY JULIA
A - Grant
Stock Option (Right to Buy)
11,996
$0.00
1
$1.61B
2021-05-05
2021-05-07
DOOGAN DECLAN
A - Grant
Stock Option (Right to Buy)
11,996
$0.00
1
$1.61B
2021-05-05
2021-05-07
CHILDS JOHN
A - Grant
Stock Option (Right to Buy)
11,996
$0.00
1
$1.61B
2020-06-09
2021-03-26
HUGIN ROBERT
A - Grant
Stock Options (Right to buy)
18,948
$0.00
1
$1.61B
2020-01-31
2021-03-26
HEFFERNAN MICHAEL THOMAS
A - Grant
Stock Option (right to buy)
26,200
$0.00
1
$1.61B
2021-03-17
2021-03-17
CHILDS JOHN
P - Purchase
Common Shares
13,157
$76.00
1000K
1
$1.61B
2020-06-17
2021-03-05
CONWAY CHARLES
Chief Scientific Officer
S - Sale
Common Shares
-4,000
$72.00
-288K
1
$1.61B
2021-03-02
2021-03-03
CHILDS JOHN
P - Purchase
Common Shares
10,000
$85.00
850K
1
$1.61B
2021-01-25
2021-02-12
CHILDS JOHN
J - Other
Common Shares
5,706
1
$1.61B
2020-10-16
2021-02-12
CORIC VLAD
Chief Executive Officer
G - Gift
Common Shares
-5,000
$0.00
2
$1.61B
2020-07-01
2021-02-12
GREGORY JULIA
S - Sale
Common Shares
-18,000
$71.00
-1.28M
2
$1.61B
2020-07-01
2021-02-12
GREGORY JULIA
M - Exercise
Common Shares
18,000
$29.00
522K
1
$1.61B
2020-07-01
2021-02-12
GREGORY JULIA
M - Exercise
Stock Option (Right to Buy)
-18,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
A - Grant
Employee Stock Option (right to buy)
40,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
A - Grant
Employee Stock Option (right to buy)
100K
$0.00
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
A - Grant
Restricted Share Unit Award
50,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
A - Grant
Restricted Share Unit Award
15,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
A - Grant
Restricted Share Unit Award
20,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
A - Grant
Employee Stock Option (right to buy)
30,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
A - Grant
Restricted Share Unit Award
20,000
$0.00
2
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
A - Grant
Employee Stock Option (right to buy)
10,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
A - Grant
Restricted Share Unit Award
5,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
F - Tax
Common Shares
-1,747
$83.00
-145K
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
F - Tax
Common Shares
-5,802
$83.00
-482K
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
F - Tax
Common Shares
-1,747
$83.00
-145K
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
F - Tax
Common Shares
-1,747
$83.00
-145K
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
F - Tax
Common Shares
-2,124
$83.00
-176K
1
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
F - Tax
Common Shares
-1,747
$83.00
-145K
1
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
F - Tax
Common Shares
-492
$83.00
-40,836
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
CONWAY CHARLES
Chief Scientific Officer
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
M - Exercise
Restricted Share Unit Award
-12,500
$0.00
1
$1.61B
2021-01-06
2021-01-08
CORIC VLAD
Chief Executive Officer
M - Exercise
Common Shares
12,500
$0.00
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
ENGELHART JAMES
Chief Financial Officer
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Restricted Share Unit Award
-3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
GENTILE KIMBERLY
SVP, Clinical Operations
M - Exercise
Common Shares
3,750
$0.00
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
JONES WILLIAM JR
CCO-Migraine & Common Disease
M - Exercise
Common Shares
5,000
$0.00
1
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
M - Exercise
Restricted Share Unit Award
-5,000
$0.00
2
$1.61B
2021-01-06
2021-01-08
STOCK ELYSE
Chief Medical Officer
M - Exercise
Common Shares
5,000
$0.00
2
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
M - Exercise
Restricted Share Unit Award
-1,250
$0.00
1
$1.61B
2021-01-06
2021-01-08
TILTON JOHN
Chief Commercial Officer
M - Exercise
Common Shares
1,250
$0.00
1
$1.61B